Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Stock availability can be subject to change without notice. We recommend calling the shop or contacting our online team to check availability of low stock items. Please see our Shopping Online page for more details.
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies.